Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, et al. J Clin Oncol 2023 Nov 17:JCO2301838. doi: 10.1200/JCO.23.01838.

Read + Share

Amedeo Smart

Independent Medical Education

Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, et al. Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. J Clin Oncol 2023 Nov 17:JCO2301838. doi: 10.1200/JCO.23.01838.
PMID: 37978951